Biomarker Assay for Residual C...
The use of tyrosine kinase inhibitors (TKI) such as imatinib mesylate (IM) targeted against BCR-ABL has proven successful in chronic...
read moreAn Update on Breast Cancer Bio...
Biomarkers are becoming key predictors of cancer outcomes, particularly in breast cancer. By identifying...
read moreCirculating DNA-Important Biom...
Circulating extracellular nucleic acids, especially DNA, was discovered more than sixty years ago, but it is becoming hot just in the...
read moreBiomarker Assay for Residual C...
The use of tyrosine kinase inhibitors (TKI) such as imatinib mesylate (IM) targeted against BCR-ABL has proven successful in chronic...
read moreStudy identifies biomarkers th...
The Stem Cells and Cancer Research Group headed by Dr H-ctor G. Palmer at the Vall d’Hebr-n Institute of Oncology (VHIO) has...
read moreSocial Media Icons
Official Website of OMICS Publishing Group
OMICS Group website helps users to navigate through information on OMICS publications and the Conferences. The OMICS Group site was established in 2007 for the scientific community. Users coming to the site can access information about individual journals based on topics/categories or alphabets, and submit manuscripts for the same. This portal also gives a detailed itinerary of the conferences that are lined up each year, with a provision to submit abstracts by speakers.